NYSE:VNEVeoneer Stock Price, Forecast & News

Veoneer's stock was trading at $8.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, VNE stock has increased by 26.5% and is now trading at $11.37. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Veoneer.

Veoneer is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for Veoneer.

Veoneer Inc (NYSE:VNE) issued its quarterly earnings results on Friday, April, 24th. The company reported ($1.49) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.34) by $0.15. The company had revenue of $362 million for the quarter, compared to analyst estimates of $359 million. Veoneer had a negative net margin of 33.63% and a negative return on equity of 29.08%. View Veoneer's earnings history.

7 Wall Street analysts have issued 1 year target prices for Veoneer's shares. Their forecasts range from $9.00 to $20.00. On average, they anticipate Veoneer's share price to reach $13.17 in the next twelve months. This suggests a possible upside of 15.8% from the stock's current price. View analysts' price targets for Veoneer.

News stories about VNE stock have been trending negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Veoneer earned a daily sentiment score of -2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news about Veoneer.

Some companies that are related to Veoneer include Allison Transmission (ALSN), LCI Industries (LCII), Dorman Products (DORM), Dana (DAN), Adient (ADNT), Meritor (MTOR), Delphi Technologies (DLPH), Gentherm (THRM), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Tower International (TOWR), Stoneridge (SRI), Garrett Motion (GTX), Tenneco (TEN) and IOCHPE MAXION S/S (IOCJY). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Pfizer (PFE), Autoliv (ALV), Franklin Resources (BEN), Canadian Natural Resources (CNQ), Constellation Pharmaceuticals (CNST), California Resources (CRC), Dominion Energy (D), Delta Air Lines (DAL), Enterprise Products Partners (EPD) and Gilead Sciences (GILD).

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer's stock is owned by a number of institutional and retail investors. Top institutional investors include DNB Asset Management AS (1.32%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View institutional ownership trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS. View insider buying and selling activity for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $11.37.

Veoneer has a market capitalization of $1.27 billion and generates $1.90 billion in revenue each year. The company earns $-500,000,000.00 in net income (profit) each year or ($4.92) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.

The official website for Veoneer is www.veoneer.com.

Veoneer's mailing address is KLARABERGSVIADUKTEN 70 SECTION C6 BOX 13089, STOCKHOLM V7, 10302. The company can be reached via phone at 248-223-0600 or via email at [email protected]